Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Madrigal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get MDGL alerts

About Dr. Rebecca Taub

Madrigal Pharmaceuticals, Inc. reported in an 8-K filed April 17, 2025 that Dr. Rebecca Taub was appointed Senior Scientific and Medical Advisor, effective April 21, 2025. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Madrigal Pharmaceuticals, Inc. includes Bill Sibold (CEO and Board Member), Julian C. Baker (Chairman and Board Member), Mardi Dier (CFO) and 7 others.

“effective as of April 21, 2025, Dr. Taub will transition from her current role and responsibilities to a new role as a Senior Scientific and Medical Advisor to the Company through the end of 2025.”
Madrigal Pharmaceuticals, Inc. Form 8-K, filed April 17, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Madrigal Pharmaceuticals, Inc.

Recent activity